APLN and neoplasm: Next, we wanted to study the contribution of GBM cell-derived APLN to tumor angiogenesis and thus we compared vascular patterns generated by U87MG cells with a stable knock-down for APLN (U87AKD) to non-silencing control cells (U87NSC; Figure 1C–E).